Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation

Abstract

Background: The cytokine interleukin-4 (IL-4) is secreted mainly by activated T lymphocytes and characterizes the T-helper 2 (Th2) sub-type. In transplantation Th2 cells are believed to induce graft tolerance. Previous studies revealed that patients with a relatively high frequency of IL-4 producing helper T lymphocytes (HTL) before heart transplantation (HTX) had no or less rejection episodes compared with patients with a low frequency of IL-4 producing HTL. Three single nucleotide polymorphisms (SNPs) have been identified in the promoter region of the IL-4 gene, which influence promoter strength. We investigated whether there was a correlation between SNP genotypes in the IL-4 promoter and heart failure, and rejection after HTX. Methods: Seventy HTX patients, 61 donors, and 36 controls were genotyped for the 3 SNPs by sequencing. Results: Of the SNPs at −285 and −81, only the C and A alleles, respectively, were found in this study. Both alleles were found for the −590 SNP. No relation between patient genotype of the SNP at −590 and heart failure and rejection was found. However, incidence of rejection was significantly lower in patients that received a donor heart with the T-positive genotype compared with patients that received a heart from a T-negative donor. Patients who had the T-negative genotype and received a heart from a T-positive donor, suffered significantly less from rejection than T-negative patients that received a T-negative donor heart. This was not significant in the T-positive patient group. Conclusions: This indicates that IL-4 production within the donor heart and by cells from the donor is important for reducing incidence of episodes of rejection.